Author:
Atiee George,Lasseter Kenneth,Baughman Sharon,McCullough Amy,Collis Phil,Hollister Alan,Hernandez Jaime
Subject
Pharmacology (medical),Pharmacology
Reference26 articles.
1. BCX-1812 (RWJ-270201): discovery of a novel, highly potent, orally active, and selective influenza neuraminidase inhibitor through structure-based drug design;Babu;J Med Chem,2000
2. Rational design of potent sialidase-based inhibitors of influenza virus replication;Itzstein;Nature
3. Mechanism of drug inhibition and drug resistance of influenza A M2 channel;Pielak;Proc Natl Acad Sci U S A,2009
4. Clinical experience in adults and children treated with intravenous peramivir for 2009 influenza A(H1N1) under an emergency IND program in the United States;Hernandez;Clin Infect Dis,2011
5. Sorbello A Jones SC Carter W Struble K The Peramivir Safety Team. Safety of peramivir assessed under the FDA emergency use authorization (EUA) to treat hospitalized patients infected with 2009 H1N1 influenza virus
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献